{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:06:24Z","timestamp":1792415184508,"version":"4.4.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":2010,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Chronic bronchitis (CB) is characterized by productive cough with excessive mucus production, resulting in quality-of-life impairment and increased exacerbation risk. Bronchial rheoplasty uses an endobronchial catheter to apply nonthermal pulsed electrical fields to the airways. Preclinical studies have demonstrated epithelial ablation followed by regeneration of normalized epithelium.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the feasibility, safety, and initial outcomes of bronchial rheoplasty in patients with CB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Pooled analysis of two separate studies enrolling 30 patients undergoing bilateral bronchial rheoplasty was conducted. Follow-up through 6 months (primary outcome) and 12 months included assessment of adverse events, airway histology, and changes in symptoms using the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test and St. George\u2019s Respiratory Questionnaire (SGRQ).<\/jats:p>\n                    <jats:p>Measurements and Main Results: Bronchial rheoplasty was performed in all 30 patients (63% male; mean [SD] age, 67 [7.4]; mean [SD] postbronchodilator FEV1, 65% [21%]; mean [SD] COPD Assessment Test score 25.6 [7.1]; mean [SD] SGRQ score, 59.6 [15.3]). There were no device-related and four procedure-related serious adverse events through 6 months, and there were none thereafter through 12 months. The most frequent nonserious, device- and\/or procedure-related event through 6 months was mild hemoptysis in 47% (14 of 30) patients. Histologically, the mean goblet cell hyperplasia score was reduced by a statistically significant amount (P\u2009&amp;lt;\u20090.001). Significant changes from baseline to 6 months in COPD Assessment Test (mean, \u22127.9; median, \u22128.0; P\u2009=\u20090.0002) and SGRQ (mean, \u221214.6; median, \u22127.2; P\u2009=\u20090.0002) scores were observed, with similar observations through 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides the first clinical evidence of the feasibility, safety, and initial outcomes of bronchial rheoplasty in symptomatic patients with CB.<\/jats:p>\n                    <jats:p>Clinical trial registered with www.anzctr.org.au (ACTRN 12617000330347) and clinicaltrials.gov (NCT 03107494).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201908-1546oc","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T17:02:13Z","timestamp":1589475733000},"page":"681-689","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":71,"title":["Bronchial Rheoplasty for Treatment of Chronic Bronchitis. Twelve-Month Results from a Multicenter Clinical Trial"],"prefix":"10.1093","volume":"202","author":[{"given":"Arschang","family":"Valipour","sequence":"first","affiliation":[{"name":"Karl Landsteiner Institute for Lung Research and Pulmonary Oncology, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Fernandez-Bussy","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, German Clinic of Santiago, Chile"},{"name":"Department of Pulmonary Medicine, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin J.","family":"Ing","sequence":"additional","affiliation":[{"name":"MQ Health, Macquarie University Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Steinfort","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Melbourne, Parkville, Victoria, Australia"},{"name":"Department of Respiratory Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory I.","family":"Snell","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Alfred Hospital, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Williamson","sequence":"additional","affiliation":[{"name":"MQ Health, Macquarie University Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tajalli","family":"Saghaie","sequence":"additional","affiliation":[{"name":"MQ Health, Macquarie University Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis B.","family":"Irving","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Melbourne, Parkville, Victoria, Australia"},{"name":"Department of Respiratory Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli J.","family":"Dabscheck","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Alfred Hospital, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Krimsky","sequence":"additional","affiliation":[{"name":"Medstar Franklin Square Medical Center, Baltimore, Maryland; and"},{"name":"Gala Therapeutics, Menlo Park, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Waldstreicher","sequence":"additional","affiliation":[{"name":"Gala Therapeutics, Menlo Park, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"2026030321484005300_bib1","doi-asserted-by":"crossref","first-page":"1700214","DOI":"10.1183\/13993003.00214-2017","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary","volume":"49","author":"Vogelmeier","year":"2017","journal-title":"Eur Respir J"},{"key":"2026030321484005300_bib2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1164\/ajrccm\/151.3_Pt_1.630","article-title":"Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers","volume":"151","author":"Verra","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321484005300_bib3","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1164\/ajrccm.161.3.9907080","article-title":"Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation","volume":"161","author":"Saetta","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321484005300_bib4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1378\/chest.130.4.1102","article-title":"Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction","volume":"130","author":"Innes","year":"2006","journal-title":"Chest"},{"key":"2026030321484005300_bib5","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1164\/ajrccm.153.5.8630597","article-title":"Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity","volume":"153","author":"Vestbo","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321484005300_bib6","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1378\/chest.130.4.1129","article-title":"Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men","volume":"130","author":"Pelkonen","year":"2006","journal-title":"Chest"},{"key":"2026030321484005300_bib7","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/thx.2008.110619","article-title":"Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk","volume":"64","author":"Guerra","year":"2009","journal-title":"Thorax"},{"key":"2026030321484005300_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1183\/09031936.00022412","article-title":"Chronic cough and sputum production: a clinical COPD phenotype?","volume":"40","author":"Burgel","year":"2012","journal-title":"Eur Respir J"},{"key":"2026030321484005300_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1465-9921-15-52","article-title":"Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study","volume":"15","author":"Kim","year":"2014","journal-title":"Respir Res"},{"key":"2026030321484005300_bib10","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1513\/AnnalsATS.201512-800OC","article-title":"Persistent and newly developed chronic bronchitis are associated with worse outcomes in chronic obstructive pulmonary disease","volume":"13","author":"Kim","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2026030321484005300_bib11","doi-asserted-by":"crossref","first-page":"1602470","DOI":"10.1183\/13993003.02470-2016","article-title":"Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease","volume":"50","author":"Lahousse","year":"2017","journal-title":"Eur Respir J"},{"key":"2026030321484005300_bib12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1164\/rccm.201210-1843CI","article-title":"Chronic bronchitis and chronic obstructive pulmonary disease","volume":"187","author":"Kim","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321484005300_bib13","doi-asserted-by":"crossref","first-page":"1900734","DOI":"10.1183\/13993003.00734-2019","article-title":"Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry","volume":"54","author":"\u00c7olak","year":"2019","journal-title":"Eur Respir J"},{"key":"2026030321484005300_bib14","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1378\/chest.129.4.879","article-title":"Seven-year cumulative incidence of COPD in an age-stratified general population sample","volume":"129","author":"Lindberg","year":"2006","journal-title":"Chest"},{"key":"2026030321484005300_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1164\/rccm.200603-381OC","article-title":"Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm","volume":"175","author":"de Marco","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321484005300_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1164\/rccm.200901-0047OC","article-title":"The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort","volume":"180","author":"Kohansal","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321484005300_bib17","first-page":"149","article-title":"Roflumilast (daliresp): a novel phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease","volume":"37","author":"Baye","year":"2012","journal-title":"P&T"},{"key":"2026030321484005300_bib18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1164\/rccm.201607-1349OC","article-title":"Effect of roflumilast and inhaled corticosteroid\/long-acting \u03b22-agonist on chronic obstructive pulmonary disease exacerbations (RE(2)SPOND): a randomized clinical trial","volume":"194","author":"Martinez","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321484005300_bib19","first-page":"OA2162","article-title":"Late breaking abstract - first-in-human results of bronchial rheoplasty: an endobronchial treatment for chronic bronchitis (CB) [abstract]","volume":"52","author":"Valipour","year":"2018","journal-title":"Eur Respir J"},{"key":"2026030321484005300_bib20","first-page":"A7037","article-title":"First-in-human results of bronchial rheoplasty: an endobronchial treatment for chronic bronchitis (CB) [abstract]","volume":"199","author":"Valipour","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321484005300_bib21","first-page":"RCT448","article-title":"Late breaking abstract - bronchial rheoplasty for treatment of chronic bronchitis: 6 month results from a prospective multi-center study [abstract]","volume":"54","author":"Valipour","year":"2019","journal-title":"Eur Respir J"},{"key":"2026030321484005300_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S2213-2600(14)70001-3","article-title":"Minimum clinically important difference for the COPD Assessment Test: a prospective analysis","volume":"2","author":"Kon","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2026030321484005300_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1081\/COPD-200050513","article-title":"St. George\u2019s respiratory questionnaire: MCID","volume":"2","author":"Jones","year":"2005","journal-title":"COPD"},{"key":"2026030321484005300_bib24","volume-title":"Nonparametric statistical methods","author":"Hollander","year":"1999","edition":"2nd ed"},{"key":"2026030321484005300_bib25","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1378\/chest.08-2062","article-title":"Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects","volume":"135","author":"Burgel","year":"2009","journal-title":"Chest"},{"key":"2026030321484005300_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1513\/AnnalsATS.201807-441OC","article-title":"Safety and tolerability of comprehensive research bronchoscopy in chronic obstructive pulmonary disease: results from the SPIROMICS bronchoscopy substudy","volume":"16","author":"Wells","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2026030321484005300_bib27","doi-asserted-by":"crossref","first-page":"e0116108","DOI":"10.1371\/journal.pone.0116108","article-title":"Chronic bronchitis and current smoking are associated with more goblet cells in moderate to severe COPD and smokers without airflow obstruction","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"2026030321484005300_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/15412550802587943","article-title":"Health status and the spiral of decline","volume":"6","author":"Jones","year":"2009","journal-title":"COPD"},{"key":"2026030321484005300_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1164\/rccm.201402-0256PP","article-title":"Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1","volume":"190","author":"Coxson","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321484005300_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/resp.13215","article-title":"Peripheral airway dysfunction and relationship with symptoms in smokers with preserved spirometry","volume":"23","author":"Jetmalani","year":"2018","journal-title":"Respirology"},{"key":"2026030321484005300_bib31","author":"D\u2019Anci","journal-title":"Effectiveness and safety of bronchial thermoplasty in management of asthma."},{"key":"2026030321484005300_bib32","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1164\/rccm.201611-2220LE","article-title":"Safety and histological effect of liquid nitrogen metered spray cryotherapy in the lung","volume":"196","author":"Slebos","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321484005300_bib33","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2147\/COPD.S164055","article-title":"Alternative definitions of chronic bronchitis and their correlation with CT parameters","volume":"13","author":"Lim","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026030321484005300_bib34","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1505971","article-title":"Clinical significance of symptoms in smokers with preserved pulmonary function","volume":"374","author":"Woodruff","year":"2016","journal-title":"N Engl J Med"},{"key":"2026030321484005300_bib35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1183\/09031936.00009015","article-title":"An official American Thoracic Society\/European Respiratory Society statement: research questions in COPD","volume":"45","author":"Celli","year":"2015","journal-title":"Eur Respir J"},{"key":"2026030321484005300_bib36","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1164\/rccm.201903-0624OC","article-title":"Safety and adverse events after targeted lung denervation for symptomatic moderate to severe chronic obstructive pulmonary disease (AIRFLOW): a multicenter randomized controlled clinical trial","volume":"200","author":"Slebos","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321484005300_bib37","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(15)60001-0","article-title":"Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial","volume":"386","author":"Davey","year":"2015","journal-title":"Lancet"},{"key":"2026030321484005300_bib38","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0140-6736(11)61050-7","article-title":"Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial","volume":"378","author":"Shah","year":"2011","journal-title":"Lancet"},{"key":"2026030321484005300_bib39","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3109\/02770903.2013.794239","article-title":"Endobronchial biopsy: a guide for asthma therapy selection in the era of bronchial thermoplasty","volume":"50","author":"Gordon","year":"2013","journal-title":"J Asthma"},{"key":"2026030321484005300_bib40","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/bmj.291.6504.1235","article-title":"Reassessment of inflammation of airways in chronic bronchitis","volume":"291","author":"Mullen","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2026030321484005300_bib41","first-page":"946","article-title":"The National Institutes of Health Intermittent Positive-Pressure Breathing trial: pathology studies. II. Correlation between morphologic findings, clinical findings, and evidence of expiratory air-flow obstruction","volume":"132","author":"Nagai","year":"1985","journal-title":"Am Rev Respir Dis"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/202\/5\/681\/67177436\/ajrccm_202_5_681.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/202\/5\/681\/67177436\/ajrccm_202_5_681.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:48:52Z","timestamp":1772592532000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/202\/5\/681\/8495269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,9,1]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201908-1546oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,9,1]]},"assertion":[{"value":"2019-08-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}